Suppr超能文献

两种多跨内质网蛋白HMG-CoA还原酶和Insig-1在前往蛋白酶体降解的途中发生错位。

Dislocation of HMG-CoA reductase and Insig-1, two polytopic endoplasmic reticulum proteins, en route to proteasomal degradation.

作者信息

Leichner Gil S, Avner Rachel, Harats Dror, Roitelman Joseph

机构信息

Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

出版信息

Mol Biol Cell. 2009 Jul;20(14):3330-41. doi: 10.1091/mbc.e08-09-0953. Epub 2009 May 20.

Abstract

The endoplasmic reticulum (ER) glycoprotein HMG-CoA reductase (HMGR) catalyzes the rate-limiting step in sterols biosynthesis. Mammalian HMGR is ubiquitinated and degraded by the proteasome when sterols accumulate in cells, representing the best example for metabolically controlled ER-associated degradation (ERAD). This regulated degradation involves the short-lived ER protein Insig-1. Here, we investigated the dislocation of these ERAD substrates to the cytosol en route to proteasomal degradation. We show that the tagged HMGR membrane region, HMG(350)-HA, the endogenous HMGR, and Insig-1-Myc, all polytopic membrane proteins, dislocate to the cytosol as intact full-length polypeptides. Dislocation of HMG(350)-HA and Insig-1-Myc requires metabolic energy and involves the AAA-ATPase p97/VCP. Sterols stimulate HMG(350)-HA and HMGR release to the cytosol concurrent with removal of their N-glycan by cytosolic peptide:N-glycanase. Sterols neither accelerate dislocation nor stimulate deglycosylation of ubiquitination-defective HMG(350)-HA((K89 + 248R)) mutant. Dislocation of HMG(350)-HA depends on Insig-1-Myc, whose dislocation and degradation are sterol independent. Coimmunoprecipitation experiments demonstrate sterol-stimulated association between HMG(350)-HA and Insig-1-Myc. Sterols do not enhance binding to Insig-1-Myc of HMG(350)-HA mutated in its sterol-sensing domain or of HMG(350)-HA((K89 + 248R)). Wild-type HMG(350)-HA and Insig-1-Myc coimmunoprecipitate from the soluble fraction only when both proteins were coexpressed in the same cell, indicating their encounter before or during dislocation, raising the possibility that they are dislocated as a tightly bound complex.

摘要

内质网(ER)糖蛋白HMG-CoA还原酶(HMGR)催化甾醇生物合成中的限速步骤。当甾醇在细胞中积累时,哺乳动物HMGR会被泛素化并通过蛋白酶体降解,这是代谢控制的内质网相关降解(ERAD)的最佳实例。这种受调控的降解涉及寿命较短的内质网蛋白Insig-1。在此,我们研究了这些ERAD底物在通向蛋白酶体降解的过程中向胞质溶胶的错位。我们发现,带有标签的HMGR膜区域HMG(350)-HA、内源性HMGR和Insig-1-Myc,所有这些多聚体膜蛋白,都会作为完整的全长多肽错位到胞质溶胶中。HMG(350)-HA和Insig-1-Myc的错位需要代谢能量,并且涉及AAA-ATP酶p97/VCP。甾醇刺激HMG(350)-HA和HMGR释放到胞质溶胶中,同时其N-聚糖被胞质肽:N-聚糖酶去除。甾醇既不加速泛素化缺陷型HMG(350)-HA((K89 + 248R))突变体的错位,也不刺激其去糖基化。HMG(350)-HA的错位依赖于Insig-1-Myc,其错位和降解与甾醇无关。免疫共沉淀实验证明了甾醇刺激的HMG(350)-HA与Insig-1-Myc之间的结合。甾醇不会增强在其甾醇感应结构域发生突变的HMG(350)-HA或HMG(350)-HA((K89 + 248R))与Insig-1-Myc的结合。仅当野生型HMG(350)-HA和Insig-1-Myc在同一细胞中共表达时,它们才会从可溶性部分中共免疫沉淀,这表明它们在错位之前或期间相遇,增加了它们作为紧密结合复合物错位的可能性。

相似文献

引用本文的文献

3
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.甲羟戊酸途径,癌症治疗中的一个代谢靶点。
Front Oncol. 2021 Feb 25;11:626971. doi: 10.3389/fonc.2021.626971. eCollection 2021.
4
Targeting ERK-Hippo Interplay in Cancer Therapy.靶向 ERK-Hippo 相互作用的癌症治疗。
Int J Mol Sci. 2020 May 3;21(9):3236. doi: 10.3390/ijms21093236.

本文引用的文献

5
The activities and function of molecular chaperones in the endoplasmic reticulum.内质网中分子伴侣的活性与功能。
Semin Cell Dev Biol. 2007 Dec;18(6):751-61. doi: 10.1016/j.semcdb.2007.09.001. Epub 2007 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验